From nutraceutical to clinical trial: frontiers in Ganoderma development

Area of Science:

• Mycology
• Pharmacology
• Biotechnology

Background:

• Ganoderma species are recognized as medicinal mushrooms with diverse pharmacological properties.
• They are valued as nutraceuticals for health improvement and disease management.
• Key bioactive metabolites include polysaccharides and ganoderic acids, known for anti-tumor and immunomodulatory effects.

Purpose of the Study:

• To review the current advancements in Ganoderma research.
• To cover bioactive metabolites, bioactivities, production methods, and clinical applications.
• To highlight the potential of Ganoderma in health and medicine.

Main Methods:

• Literature review of studies on Ganoderma.
• Analysis of research on bioactive metabolites and their functions.
• Examination of production techniques, including industrial submerged fermentation.
• Overview of clinical trial data.

Main Results:

• Ganoderma possesses a wide range of bioactivities, including anti-tumor, immunomodulation, skin lightening, gut microbiota regulation, and anti-viral effects.
• Industrial submerged fermentation of Ganoderma mycelia is a viable method to increase biomass and bioactive metabolite production.
• Advanced production strategies like gene regulation and environmental control (pH, oxygen) optimize metabolite yield.
• Ganoderma is increasingly used as a popular nutraceutical and is being investigated in clinical trials for cancers.

Conclusions:

• Ganoderma mushrooms are a rich source of pharmacologically active compounds with significant health benefits.
• Industrial fermentation offers a scalable and cost-effective approach to harness Ganoderma's therapeutic potential.
• Ongoing research and clinical trials support the expanding applications of Ganoderma in medicine and wellness.